WIM
IMVT icon

Wittenberg Investment Management’s Immunovant IMVT Stock Holding History

Wittenberg Investment Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-107,498
Closed -$600K – 84
2022
Q3 		$600K Sell
107,498
-66,502
-38% -$325K 0.26% 53
2022
Q2 		$679K Buy
174,000
+33,500
+24% +$145K 0.29% 48
2022
Q1 		$774K Hold
140,500
– – 0.29% 45
2021
Q4 		$1.2M Hold
140,500
– – 0.43% 35
2021
Q3 		$1.22M Buy
140,500
+76,500
+120% +$690K 0.47% 32
2021
Q2 		$676K Buy
+64,000
New +$894K 0.27% 41

Other funds holding IMVT

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Wittenberg Investment Management's IMVT Position: Q4 2022 in Review

Wittenberg Investment Management sold out of Immunovant (IMVT) in Q4 2022, closing a stake of 107,498 shares — an estimated $600K sold.

Wittenberg Investment Management first reported a position in IMVT in Q2 2021 and held it in 6 quarters. The position peaked at $1.22M in Q3 2021. 133 funds tracked by Wall St. Rank hold IMVT as of Q4 2022.

  • Wittenberg Investment Management reported no remaining Immunovant position as of Q4 2022 after selling out during the quarter.
  • Wittenberg Investment Management sold 107,498 Immunovant shares in Q4 2022, an estimated $600K.
  • Wittenberg Investment Management first reported a position in Immunovant in Q2 2021 and held it in 6 quarters.
  • Wittenberg Investment Management's Immunovant position peaked at $1.22M in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Immunovant as of Q4 2022.

Based on Wittenberg Investment Management's 13F filing for Q4 2022, filed 6 Feb 2023.